St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety more

4 cheap small cap stocks I’ve got my eye for Christmas more

Southern Biologics Network Established to Create Biologics Faster and Less Expensively more

Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more

RBA to cut rates in 2015: Still want to invest in term deposits? more

Can robots help stop the Ebola outbreak? more

Robots Help Fight Ebola more

South Florida Hospital Unveils Ebola-Zapping Robot more

Sonoma Valley Hospital uses robot to kill germs more

Robots go to war against Ebola more

New iTraumaCare CEO to pursue big growth more

UAB and SRI have plans to spinoff more success more

Launch of Galderma's new acne products more

iTraumaCare’s new CEO to help company secure new funding more

U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more

Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil more

Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more

Robot fights germs at Sharp Chula Vista Medical Center more

Xenex updates protocols for germ-zapping robots in response to Ebola threat

Dealing with highly infectious diseases like Ebola is often like a logic problem. Disinfecting rooms is hard enough, but what about protective suits? True, they greatly reduce the chances of infection, but getting them off can bring the risk straight back again if the suit isn't decontaminated first. Texas-based Xenex has created protocols that conform to those of the US Centers for Disease Control and Prevention (CDC) for its a line of robots that use UV lamps that to decontaminate hospital rooms and protective clothing exposed to the Ebola virus, so they can be safely removed.

Xenex robots use the company’s Full Spectrum ultraviolet radiation system to disinfect areas and protective clothing before workers remove them, which greatly reduces the chance of infection from handling the outside of the suits and gloves. According to Xenex, its robots are more effective than conventional mercury UV lamps, can disinfect an area in five to ten minutes, are easily integrated into existing hospital procedures, and protective garments can be disinfected and made safe to remove in five minutes. Not to mention that using robots for the task means fewer people are exposed to the danger.

The system uses a high-intensity xenon UV lamp that pulses in the ultraviolet C band covering 200 to 280 nanometers twice a second, as opposed to a mercury lamp’s 258 nanometers. This broad waveband penetrates the microbe’s cell walls and fuse its DNA, rendering it incapable of reproduction. The company claims that the rays can destroy not only the Ebola virus, but also Clostridium difficile (C.diff), Methicillin-resistant Staphylococcus aureus (MRSA), Enterovirus D68, VRE, and other bacteria, viruses, molds, fungi, and spores. The company says that it is as effective as chemical disinfectants, but without the toxic side effects.

"Hospitals across the country may handle suspected Ebola cases so it’s critical for every facility to have a comprehensive plan in place to ensure the safety of healthcare workers, patients and the general public," says Dr. Mark Stibich, co-founder and Chief Scientific Officer of Xenex. "We created this Ebola protocol using our experience in over 250 hospitals, as well as laboratory data on the effectiveness of Xenex’s germ-zapping robots on Ebola-type viruses. Patients, communities, and hospital employees want reassurance their hospital is utilizing the most advanced technology available to protect them."

Source: http://www.gizmag.com back

How do we get rid of the endotoxins? Birmingham's  has the solution more

Medical Device ® Positions New Leader for Next-Level Growth more

The Xenex robot at South Shore Hospital featured on an Xploration Earth more

Germ-zapping robot Gigi sets its sights on Ebola more

Morningside Ventures leads a Series B round for DNAtrix more

StemBioSys secures new research space at BioBridge Global more

Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more

Company invents germ-zapping robot more

Xenex Congratulates Houston Cancer Hospital more

Australian grown Indian Sandalwood timber attracts lucrative Asian markets more

DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more

Targeted Technology raises more than $40 million more

Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more

Three Birmingham companies recognized in PwC report more

Former Kinetic Concepts Inc. CEO to lead StemBioSys more

International dermatology company Galderma confirmed more

AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more

San Antonio luring biotech firms with venture capital more

Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more

Birmingham is on the front lines of medical research: take a look at this incredible biotech startup more

Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more

Milford hospital enlists robots in war against infections more

Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more

Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more

Xenex Demonstrates UV Room Cleaning System’s Effectiveness in Reducing Hospital Acquired Infections more

TFS flags record full-year profit more

Sweet scented sandalwood flavour of month more

House committee looks for new technology in Veterans Affairs hospitals more

FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more

CEO shakeup at San Antonio biotech company StemBioSys more

First harvest to be completed in June more

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter more

San Antonio biotech firm readies skin treatment for distribution more

ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more

Medical technologies conference announces speaker lineup more

Australian sandalwood sells for millions more

Sandalwood exports as good as gold more

Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more

ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more

DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more

ViroXis Corporation Achieves Key Clinical Milestones more

There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more